These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24603750)

  • 1. The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease.
    Dias JC; Coura JR; Yasuda MA
    Rev Soc Bras Med Trop; 2014; 47(1):123-5. PubMed ID: 24603750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Chagas disease].
    Abitbol H
    An R Acad Nac Med (Madr); 1981; 98(4):755-8. PubMed ID: 6808853
    [No Abstract]   [Full Text] [Related]  

  • 3. The need of a neonatal preparation for Chagas disease.
    Sosa-Estani S; Belizan JM; Althabe F; Rubinstein A
    PLoS Med; 2005 Nov; 2(11):e387. PubMed ID: 16288560
    [No Abstract]   [Full Text] [Related]  

  • 4. First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.
    Salomon CJ
    J Pharm Sci; 2012 Mar; 101(3):888-94. PubMed ID: 22161779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitrypanosomal agents: treatment or threat?
    Issa VS; Bocchi EA
    Lancet; 2010 Sep; 376(9743):768; author reply 768-9. PubMed ID: 20816538
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential new clinical therapies for Chagas disease.
    Bustamante JM; Tarleton RL
    Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
    Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
    Cencig S; Coltel N; Truyens C; Carlier Y
    Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in parasitemia evaluated using the modified Strout method in patients with acute Chagas disease under treatment].
    Castro C; Emanuel A
    Rev Soc Bras Med Trop; 1988; 21(4):177-80. PubMed ID: 3152133
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review.
    Arrúa EC; Seremeta KP; Bedogni GR; Okulik NB; Salomon CJ
    Acta Trop; 2019 Oct; 198():105080. PubMed ID: 31299283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.
    Garcia-Bournissen F; Altcheh J; Giglio N; Mastrantonio G; Della Védova CO; Koren G
    Paediatr Drugs; 2009; 11(1):33-7. PubMed ID: 19127950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Chagas disease with benznidazole and thioctic acid].
    Roldán EJ
    Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and developing therapeutic agents in the treatment of Chagas disease.
    Apt W
    Drug Des Devel Ther; 2010 Sep; 4():243-53. PubMed ID: 20957215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chagas' disease.
    Montero A; Giovannoni AG
    Lancet; 2001 Jul; 358(9275):74. PubMed ID: 11458940
    [No Abstract]   [Full Text] [Related]  

  • 15. Spanish group defeats Shkreli in Chagas voucher race.
    Melton L
    Nat Biotechnol; 2017 Nov; 35(11):1003. PubMed ID: 29121016
    [No Abstract]   [Full Text] [Related]  

  • 16. Access to benznidazole for Chagas disease in the United States-Cautious optimism?
    Alpern JD; Lopez-Velez R; Stauffer WM
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005794. PubMed ID: 28910299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Siqueira-Neto JL
    Rev Soc Bras Med Trop; 2018; 51(2):123-124. PubMed ID: 29768542
    [No Abstract]   [Full Text] [Related]  

  • 18. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Exp Parasitol; 1998 Jun; 89(2):251-6. PubMed ID: 9635449
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanotechnological approaches against Chagas disease.
    Romero EL; Morilla MJ
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):576-88. PubMed ID: 19941920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
    Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
    Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.